source
- STAT+: Oruka’s long-acting psoriasis therapy posts strong results in mid-stage studyA long-acting injectable treatment for plaque psoriasis helped 63% of patients achieve complete skin clearance in a clinical trial, its maker, Oruka Therapeutics, reported.STAT · 3mo ago↗ source
- STAT+: Zap in a cap: How one neurotech startup is using a hat to treat depressionFDA approved a request from Motif Neurotech, to start an initial feasibility trial to test a brain implant to treat depression.STAT · 3mo ago↗ source
- NIH-funded research lags in reporting sex differences, new study findsFewer than half of papers published by NIH-funded researchers analyze or report their data by sex, a new study found.STAT · 3mo ago↗ source